Press Releases | Medtronic

Month Year

Email alerts

Jan 30, 2012

Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices

New System Builds On Sprint Quattro® Lead, Adding to the Company’s Portfolio of Innovative Technologies Proven to Treat Heart Rhythm Disorders

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 30, 2012-- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a...
Jan 30, 2012

Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve® System Using Direct Aortic Approach

Multicenter Experience Demonstrates Surgical Approach, with Recent CE Mark, is a Feasible Alternative for Transcatheter Aortic Valve Implantation

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 30, 2012-- Medtronic, Inc. (NYSE: MDT) today issued a statement on the results of two studies evaluating the use of the Medtronic CoreValve® System delivered...
Jan 30, 2012

Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve(R) System Using Direct Aortic Approach

Multicenter Experience Demonstrates Surgical Approach, with Recent CE Mark, is a Feasible Alternative for Transcatheter Aortic Valve Implantation

MINNEAPOLIS, Jan 30, 2012 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today issued a statement on the results of two studies evaluating the use of the Medtronic CoreValve(R) System delivered...
Jan 27, 2012

Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami Instruments

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 27, 2012-- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into an exclusive distribution agreement with Miami Instruments, LLC – a company...
Jan 24, 2012

First Patient Enrolled in Medtronic-Supported Head-to-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 24, 2012-- Medtronic, Inc. (NYSE: MDT) today announced the first patient was enrolled in the FIRE AND ICE clinical trial, which is a prospective, randomized,...
Jan 24, 2012

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve(R) U.S. Pivotal Trial

CoreValve U.S. Trial to Continue Enrolling Patients in High Risk Study, and Will Maintain Therapy Access to Extreme Risk Patients via Continued Access Phase of Trial

MINNEAPOLIS, Jan 24, 2012 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The...
Jan 23, 2012

Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 23, 2012-- Medtronic, Inc. (NYSE:MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys® SBS...
Jan 17, 2012

Medtronic Endurant® II AAA Stent Graft System Launches Internationally with CE Mark

Enhanced Medical Device to Repair Abdominal Aortic Aneurysms Without Open Surgery Expands Physicians’ Options for Treating ‘Silent Killer’

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 17, 2012-- Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant®II AAA Stent Graft System,...
Jan 17, 2012

Medtronic Endurant(R) II AAA Stent Graft System Launches Internationally with CE Mark

Enhanced Medical Device to Repair Abdominal Aortic Aneurysms Without Open Surgery Expands Physicians' Options for Treating 'Silent Killer'

MINNEAPOLIS, Jan 17, 2012 (BUSINESS WIRE) --Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant(R) II AAA Stent Graft System,...
Jan 4, 2012

Medtronic Launches First-of-Its-Kind mySentry(TM) Remote Glucose Monitor

mySentry Allows Caregivers to See Real-Time Insulin Pump Information and Glucose Trends from Another Room

MINNEAPOLIS--(BUSINESS WIRE)--Jan. 4, 2012-- Today, Medtronic, Inc. (NYSE:MDT) announced U.S. Food and Drug Administration (FDA) approval and U.S. market launch of the first-of-its-kind...
Dec 23, 2011

Medtronic CEO Omar Ishrak to Speak at JP Morgan Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 23, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the 30th Annual JP Morgan...
Dec 20, 2011

Medtronic CEO Omar Ishrak to Speak at Goldman Sachs CEO Conference

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 22, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare...
Dec 12, 2011

Medtronic Reaches Settlement with United States Department of Justice

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 12, 2011-- Medtronic, Inc. (NYSE: MDT) today announced that the Company has reached a settlement agreement with the United States Department of Justice (DOJ)...
Dec 10, 2011

Medtronic to Announce Financial Results for Its Second Quarter of the Fiscal Year 2012

MINNEAPOLIS, Nov 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2012 on Tuesday, November 22,...
Dec 9, 2011

Data Shows Medtronic AdaptiveStim™ with RestoreSensor™ Provides Pain Relief and Convenience

Neurostimulator with Innovative Motion Sensor Technology Was Recently Approved by the FDA for the Management of Chronic Pain

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 9, 2011-- Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStim™ with...
Dec 8, 2011

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2012

MINNEAPOLIS, Dec 08, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.2425 per share of the Company's common stock. The dividend is...
Dec 7, 2011

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 7, 2011-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel determined...
Nov 21, 2011

Medtronic CFO Gary Ellis to Speak at Piper Jaffray Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 21, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray Healthcare...
Nov 20, 2011

Medtronic Reports Second Quarter Earnings

Revenue of $4.1 Billion Grew 3% on a Constant Currency Basis, 6% as Reported

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2012, which ended October 28, 2011. The company...
Nov 20, 2011

Medtronic Receives FDA Approval for Next Generation Professional Continuous Glucose Monitoring

iPro®2 Simplifies Professional CGM for Improved Diabetes Therapy Management

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro®2, a next generation Professional continuous...
Nov 17, 2011

Bain Capital to Acquire Physio-Control from Medtronic

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE:MDT) and Bain Capital, a leading global private investment firm, today announced they have entered into a definitive...
Nov 17, 2011

Medtronic Receives FDA Approval of AdaptiveStim(TM) with RestoreSensor(TM) for the Management of Chronic Pain

Neurostimulator Uses Innovative Motion Sensor Technology to Provide Patient Comfort and Convenience

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food & Drug Administration (FDA) approval of its AdaptiveStim™ with RestoreSensor™...
Nov 10, 2011

Actress and Dancer Debbie Allen Teams Up With Medtronic and Urges Americans to "Join the Pace Makers"

Campaign Empowers People With a Slow Heartbeat to Learn About Treatment Options and How to Have an Informed Discussion With Their Doctor

Famed dancer, actress, and director Debbie Allen has teamed up with Medtronic, Inc. (NYSE: MDT) today to kick off "Join the Pace Makers," a national campaign designed to empower people with a...
Nov 9, 2011

Retrospective Study Shows New Device Significantly Reduces Blood Loss and Transfusions in Adolescent Scoliosis Corrective Surgery

MINNEAPOLIS, Nov 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today reported results of an retrospective study available online and in an upcoming print edition of the Journal of Spinal...
Nov 9, 2011

Medtronic Begins Enrolling U.S. IDE Study of EnliteTM Sensor for Continuous Glucose Monitoring

Study Will Evaluate Accuracy of Latest Innovation to Help People with Diabetes Improve Glucose Control

MINNEAPOLIS, Nov 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in...
Nov 8, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

Pooled Data Analyses to Be Presented at TCT 2011 Demonstrate Heart Device's Consistently Positive Performance Across Multiple Clinical Studies

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT)...
Nov 8, 2011

Study of Medtronic Endeavor(R) Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus(R) DES

Final Five-Year Follow-up of Randomized ENDEAVOR IV Trial Shows Durable Safety and Efficacy of Endeavor DES, with Comparatively Lower Rates of Cardiac Death/Myocardial Infarction and Very Late Stent Thrombosis

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- New research findings released at TCT 2011 show that the Endeavor(R) zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed...
Nov 7, 2011

Medtronic CoreValve(R) System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation

New Access Will Expand Treatment Options for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Nov 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered...
Nov 4, 2011

Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Presentations Cover Stents and Balloons for Coronary and Peripheral Artery Disease, Transcatheter Valve for Aortic Stenosis, Stent Grafts for Aortic Aneurysms, and Renal Denervation for Treatment-Resistant Hypertension and Heart Failure

MINNEAPOLIS, Nov 04, 2011 (BUSINESS WIRE) -- Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT)...
Nov 3, 2011

Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device

The latest advancement in expandable cage technology for surgeons, hospitals and patients

MEMPHIS, Tenn., Nov 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced the global launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device in the U.S. and Europe today at the North...
Nov 2, 2011

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the...
Nov 2, 2011

Medtronic Introduces New Procedure for Minimally Invasive Spinal Fusion

MEMPHIS, Tenn., Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th
Nov 2, 2011

Medtronic Announces Launch of Mini EVS 3.4 Epidural Vein Sealer at 26th Annual Meeting of North American Spine Society

MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- To address surgeon needs of rapidly managing hemostasis in minimally invasive spine surgery, Medtronic, Inc. (NYSE: MDT) announced today the launch of...
Oct 31, 2011

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

Assurant(R) Cobalt Iliac Stent Features Novel Alloy and Modular Design; Augments Company's Peripheral Portfolio with Balloon-Expandable Option

MINNEAPOLIS, Oct 31, 2011 (BUSINESS WIRE) -- Advancing the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug Administration...
Oct 28, 2011

Medtronic Named One of the "World's 25 Best Multinational Workplaces"

MINNEAPOLIS, Oct 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today The Great Place to Work Institute(R) included the company on the inaugural "World's 25 Best Multinational...
Oct 28, 2011

Medtronic Receives IDE Approval to Conduct ASPIRE In-Home Study of First Insulin Pump with Low Glucose Suspend for US Market

A Critical Step Toward the Development of an Artificial Pancreas, Low Glucose Suspend Aims to Reduce Hypoglycemia

MINNEAPOLIS, Oct 28, 2011 (BUSINESS WIRE) -- In our continued commitment to develop an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA)...
Oct 27, 2011

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

MINNEAPOLIS, Oct 27, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against...
Oct 26, 2011

Medtronic Starts Landmark Study of Hypertension Treatment

U.S. Clinical Trial of Symplicity(R) Renal Denervation System(TM) Enrolls First Patient

MINNEAPOLIS, Oct 26, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity(R) Renal Denervation...
Oct 17, 2011

Medtronic Announces 510(k) Clearance for theAquamantys(R)3 System with Combined Hemostatic Sealing and Cutting Functionality

MINNEAPOLIS, Oct 17, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its Aquamantys(R)3...
Oct 17, 2011

Medtronic Elects Michael O. Leavitt to the Board of Directors

MINNEAPOLIS, Oct 17, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors unanimously voted to elect Michael O. Leavitt, founder and chairman of Leavitt...
Oct 13, 2011

Medtronic Introduces Two Next-Generation Cardiovascular Devices in Japan

Integrity(R) Coronary Stent Redefines Deliverability with Continuous Sinusoid Technology; Endurant(R) AAA Stent Graft Expands Applicability of Endovascular Aortic Repair

MINNEAPOLIS, Oct 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced plans to introduce two of its next-generation cardiovascular devices in Japan, the world's second largest...
Oct 10, 2011

Medtronic Announces Results from TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

First Ever Randomized, Controlled Clinical Trial in Persistent Atrial Fibrillation (AF) Patients

VENICE, Italy & MINNEAPOLIS, Oct 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced results from its Tailored Treatment of Permanent Atrial Fibrillation (TTOP-AF) clinical...
Sep 27, 2011

Medtronic Announces Start of Pivotal Trial for EngagerTM Transcatheter Aortic Valve Implantation System

Study will evaluate new therapy option for patients suffering from valvular heart disease

MINNEAPOLIS, Sep 27, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the start of the Engager(TM) European Pivotal Trial to pursue CE (Conformité Européenne) Mark for the...
Sep 20, 2011

Medtronic Responds to United Nations High-Level Meeting on Noncommunicable Diseases

MINNEAPOLIS, Sep 20, 2011 (BUSINESS WIRE) -- Following are statements from Herb Riband, Medtronic vice president of external affairs, and Dr. Jacob Gayle, vice president of Medtronic Foundation...
Sep 20, 2011

Jury Awards Medtronic $101 Million in Patent Suit against NuVasive

MEMPHIS, Tenn., Sep 20, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today that a jury in the United States District Court of the Southern District of California in San Diego,...
Sep 15, 2011

Medtronic Announces 510(k) Clearance for the TSRH(R) Spinal System Pedicle Screw for the Treatment of Adolescent Idiopathic Scoliosis

AIS is the Most Common Type of Scoliosis Seen in Adolescents and Affects Nearly One Million Adolescents in the U.S. Alone

MEMPHIS, Tenn., Sep 15, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it received a second clearance from the Food and Drug Administration (FDA) to treat adolescent idiopathic...
Sep 14, 2011

Medtronic Pledges Action in Advance of United Nations High Level Meeting on Noncommunicable Diseases

The World's Leading Medical Technology Company Pledges Resources to Improve Healthcare Systems and Access to Therapies in Lower- and Middle-Income Countries

MINNEAPOLIS, Sep 14, 2011 (BUSINESS WIRE) -- In a continued mission to reduce the global burden of noncommunicable diseases (NCDs) such as cardiovascular disease and diabetes, Medtronic, Inc....
Sep 12, 2011

Medtronic Announces Launch of ARTISAN(TM) Space Maintenance System

New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications

MEMPHIS, Tenn., Sep 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today the U.S. launch of its ARTISAN(TM) Space Maintenance System. The device is cleared for temporary use in...
Sep 8, 2011

Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference

MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global...
Sep 8, 2011

Medtronic Named to Dow Jones Sustainability World Index

Index Acknowledge Corporate Sustainability Accomplishments

MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
Aug 31, 2011

Medtronic Starts New U.S. Study of Endurant(R) AAA Stent Graft

Indicated for Endovascular Treatment of Abdominal Aortic Aneurysms, Medical Device Has Been Used to Treat More Than 6,000 Patients in United States Since December FDA Approval

MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the start of its U.S. post-approval study of...
Aug 31, 2011

Medtronic Completes Acquisitions of PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.

Medtronic Expands Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...
Aug 28, 2011

Study Shows Medtronic CoreValve(R) System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

PARIS, Aug 28, 2011 (BUSINESS WIRE) -- New clinical data presented today at the European Society of Cardiology Congress 2011 demonstrate positive long-term performance for the CoreValve(R)...
Aug 25, 2011

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2012

MINNEAPOLIS, Aug 25, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.2425 per share of the Company's common stock. The dividend is...
Aug 24, 2011

Physio-Control Introduces New Basic Life Support 12-Lead ECG Solution

ReadyLink 12-Lead ECG Enables Rural EMS Providers to Expand Regional STEMI Systems

REDMOND, Wash., Aug 24, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), today announced...
Aug 23, 2011

Medtronic Reports First Quarter Earnings

Revenue of $4 Billion Driven by International Growth of 7% on a Constant Currency Basis; 19% as Reported

MINNEAPOLIS, Aug 23, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011. The Company...
Aug 20, 2011

Medical Device Recipient Successfully Crosses English Channel to Raise Money for ALS (Lou Gehrig's Disease)

MEMPHIS, Tenn., Aug 22, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced cervical disc recipient Doug McConnell successfully completed his swim across the English Channel today. McConnell,...
Aug 18, 2011

Medtronic Gains CE Mark for 31mm CoreValve(R) Percutaneous Aortic Valve

New Offering Provides Therapy Option to Previously Unserved Patients with Larger Aortic Valves

MINNEAPOLIS, Aug 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for its 31mm Medtronic CoreValve(R) System, the only...
Aug 15, 2011

Study Shows Medtronic InterStim(R) Therapy Improves Bowel Control and Related Quality of Life Issues at Three Years

InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA

MINNEAPOLIS, Aug 15, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using...
Aug 12, 2011

Medtronic to Announce Financial Results for Its First Quarter of the Fiscal Year 2012

MINNEAPOLIS, Aug 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2012 on Tuesday, August 23, 2011....
Aug 5, 2011

Medtronic to Webcast Annual Shareholder Meeting

MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
Aug 3, 2011

Medtronic Engages Yale University to Oversee Independent, Systematic Reviews of Recombinant Bone Morphogenic Protein-2

First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data

MINNEAPOLIS, Aug 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. [NYSE: MDT] announced today that it has provided a grant to Yale University to conduct two fully independent, third-party systematic...
Aug 1, 2011

Medtronic Receives FDA Approval for Advisa DR MRI(TM) SureScan(R) Pacing System Clinical Trial

Investigational Second-Generation Device Reinforces Medtronic's Commitment to Innovative Implantable Cardiac Devices Designed for Use in MRI Environment

MINNEAPOLIS, Aug 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...
Jul 25, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Superiority to Taxus(R) DES in Study of Patients with Coronary Artery Disease

Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval

MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
Jul 21, 2011

Medtronic Announces 2011 "Global Heroes"

Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall

MINNEAPOLIS, Jul 21, 2011 (BUSINESS WIRE) -- Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run the Medtronic Twin...
Jul 11, 2011

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon

MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
Jul 8, 2011

Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed(R) II Implantable Drug Infusion Pumps

Update to July 2009 Letter to Healthcare Professionals

MINNEAPOLIS, Jul 08, 2011 (BUSINESS WIRE) -- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing...
Jul 7, 2011

Medtronic To Acquire Salient Surgical Technologies, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
Jul 7, 2011

Medtronic To Acquire PEAK Surgical, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
Jul 1, 2011

Medtronic Introduces the CD HORIZON(R) Fenestrated Screw Spinal System

Europe first in line to receive Medtronic's innovative product

MEMPHIS, Tenn., Jul 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the European launch of the CD HORIZON(R) Fenestrated Screw Spinal System, which is used in conjunction...
Jun 30, 2011

Medtronic Announces U.S. Launch of New Inflatable Bone Tamp and Syringe System for Treatment of Vertebral Compression Fractures

Kyphon Xpander(TM) II Inflatable Bone Tamp and the Kyphon(R) Inflation Syringe are Latest Innovation in Minimally Invasive Treatment of Spinal Fractures

MEMPHIS, Tenn., Jun 30, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation...
Jun 29, 2011

Medtronic Commends Congress and the Institute of Medicine on Study on Advancing Pain Research, Care and Education

MINNEAPOLIS, Jun 29, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of...
Jun 28, 2011

Medtronic Introduces an Innovative Mobile Application for the CareLink(R) Network

The CareLink(TM) Mobile Application Offers Direct Mobile Access to Data on the Medtronic CareLink(R) Network

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care...
Jun 28, 2011

Medtronic CEO Omar Ishrak Statement on rhBMP-2 Articles in Spine Journal

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant...
Jun 25, 2011

Research Presented at ADA Adds to the Clinical Evidence for Medtronic's Sensor-Augmented Insulin Pump Therapy

STAR 3 Continuation Data, Low Glucose Suspend and Patient Reported Outcomes Highlighted at American Diabetes Association's 71st Scientific Sessions

SAN DIEGO, Jun 25, 2011 (BUSINESS WIRE) -- Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's...
Jun 23, 2011

Medtronic Board Increases Cash Dividend by Eight Percent; Increases Share Repurchase Plan

MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
Jun 18, 2011

VALOR II Study Highlights Strengths of Valiant(R) Thoracic Stent Graft from Medtronic

Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study

MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
Jun 13, 2011

Company Profile for Medtronic, Inc.

Company Profile for Medtronic, Inc. Jun 13, 2011 (BUSINESS WIRE) -- Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with...
Jun 3, 2011

Medtronic CFO Gary Ellis to Speak at Goldman Sachs Healthcare Conference

MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
May 24, 2011

Medtronic Reports Fourth Quarter Earnings

Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
May 24, 2011

Medtronic Provides Initial Revenue Outlook and EPS Guidance for Fiscal Year 2012

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
May 20, 2011

Medtronic Resolute(R) Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

Late-breaker at EuroPCR Confirms Low Rates of Adverse Events with Novel Heart Device in More Than 5,000 Study Subjects

PARIS, May 20, 2011 (BUSINESS WIRE) -- A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong...
May 20, 2011

Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System

Meta-Analysis of Seven International Clinical Registries Presented at EuroPCR 2011 Late-Breaking Presentation

PARIS, May 20, 2011 (BUSINESS WIRE) -- A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the...
May 19, 2011

Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach

New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients

PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
May 18, 2011

Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population

PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
May 17, 2011

Medtronic CoreValve(R) Multi-Center Study Shows Rapid and Sustained Health-Related Quality-of-Life Improvements

Two-year Results from Europe and Canada Represent Longest-term Quality-of-life Assessment of All Transcatheter Aortic Valves to Date

PARIS, May 17, 2011 (BUSINESS WIRE) -- New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving...
May 16, 2011

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

EuroPCR Program Includes Endovascular Late-Breakers on IN.PACT Drug-Eluting Balloons and Mo.Ma Ultra Embolic Protection System Enrollment in IN.PACT SFA I DEB Study Completed; PIs for IN.PACT SFA II Study Selected

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced...
May 16, 2011

Medtronic Launches Quick-to-Dough Bone Cement in the United States

Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
May 13, 2011

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year Ended April 29, 2011

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
May 13, 2011

Vertebral Augmentation for Spinal Fractures Continues to Be Covered by Noridian Administrative Services

Kyphon(R) Balloon Kyphoplasty is Among Treatments that Continue to be Covered by Major Medicare Administrative Contractor

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare...
May 12, 2011

Medtronic to Release New Clinical Data on Unrivaled Portfolio of Interventional Devices at EuroPCR

Highlights Include Late-Breakers and Other Scientific Sessions on CoreValve System, Resolute Drug-Eluting Stent, IN.PACT Drug-Eluting Balloons, Mo.Ma Embolic Protection System, and Renal Denervation with Symplicity Catheter System

MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- New clinical data on a range of innovative medical devices from Medtronic, Inc. (NYSE: MDT), to treat cardiac and vascular diseases - from severe...
May 10, 2011

Medtronic Board of Directors Announces Appointment of Omar Ishrak as Chairman and CEO

MINNEAPOLIS, May 11, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) announced today that its board of directors named Omar Ishrak as the company's new chairman and chief executive officer,...
May 9, 2011

Medtronic and Bayer HealthCare Expand International Alliance

MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...
May 5, 2011

Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden in Symptomatic and Asymptomatic Patients Following RF Ablation

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
May 5, 2011

New Data Shows Clinical Benefit of Cardiac Resynchronization Therapy (CRT) in Atrial Fibrillation (AF)

Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
May 5, 2011

Medtronic Announces FDA Approval of Attain Ability(R) Plus and Attain Ability(R) Straight Left-Heart Leads for Cardiac Resynchronization Therapy (CRT) Devices

New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
May 3, 2011

Physio-Control Introduces New Hospital Solutions for the LIFEPAK 15 Monitor/Defibrillator

New Feature Set Includes External AC/DC Power and Temperature Monitoring for Therapeutic Hypothermia Patients

REDMOND, Wash., May 03, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced...
May 2, 2011

Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve(TM) Mapping Catheter

New Technology Adds Diagnostic Capability to the Arctic Front(R) Cardiac CryoAblation Catheter System in Treating Paroxysmal Atrial Fibrillation

MINNEAPOLIS, May 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the...
Apr 27, 2011

Medtronic Announces Date for 2011 Annual Meeting

Shareholders Invited to Attend Annual Meeting on Aug. 25, 2011

MINNEAPOLIS, Apr 27, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT), today announced that the company's annual meeting of shareholders will be held at 10:30 a.m.,...
Apr 20, 2011

Medtronic Teams with Medical Device Recipient in English Channel Swim

Artificial Disc Recipient to Raise Funds for ALS Research

MEMPHIS, Tenn., Apr 20, 2011 (BUSINESS WIRE) -- In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel....

Show per page